STOCK TITAN

[Form 4] SELECT MEDICAL HOLDINGS CORP Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Form 144 filing: An unidentified Kinder Morgan, Inc. (KMI) insider has notified the SEC of an intent to sell up to 40,000 common shares on or about 08/04/2025 through Morgan Stanley Smith Barney. At the implied price in the notice, the block is worth approximately $1.124 million.

The shares originate from restricted stock units that vested on 07/31/2025. With roughly 2.222 billion KMI shares outstanding, the proposed sale equals less than 0.002% of total float—an amount that is not expected to influence liquidity, control, or market pricing.

No other sales were reported during the previous three-month period. The filer affirms there is no non-public adverse information, and the submission fulfills Rule 144’s advance-notice requirement. The document conveys no changes to Kinder Morgan’s operations, financial guidance, or capital structure; it is strictly a procedural disclosure of a routine, small-scale insider sale.

Deposito del modulo 144: Un dirigente non identificato di Kinder Morgan, Inc. (KMI) ha notificato alla SEC l'intenzione di vendere fino a 40.000 azioni ordinarie intorno al 04/08/2025 tramite Morgan Stanley Smith Barney. Al prezzo indicato nell'avviso, il blocco vale circa 1,124 milioni di dollari.

Le azioni derivano da unità azionarie vincolate che sono maturate il 31/07/2025. Con circa 2,222 miliardi di azioni KMI in circolazione, la vendita proposta rappresenta meno dello 0,002% del flottante totale—una quantità che non dovrebbe influenzare la liquidità, il controllo o il prezzo di mercato.

Non sono state segnalate altre vendite nel periodo di tre mesi precedente. Il dichiarante conferma che non ci sono informazioni riservate negative e che la comunicazione rispetta il requisito di preavviso della Regola 144. Il documento non segnala cambiamenti nelle operazioni, nelle previsioni finanziarie o nella struttura del capitale di Kinder Morgan; si tratta esclusivamente di una comunicazione procedurale relativa a una vendita interna di piccola entità e di routine.

Presentación del formulario 144: Un insider no identificado de Kinder Morgan, Inc. (KMI) ha notificado a la SEC su la intención de vender hasta 40,000 acciones comunes alrededor del 04/08/2025 a través de Morgan Stanley Smith Barney. Al precio implícito en el aviso, el bloque tiene un valor aproximado de 1.124 millones de dólares.

Las acciones provienen de unidades restringidas de acciones que se consolidaron el 31/07/2025. Con aproximadamente 2.222 mil millones de acciones KMI en circulación, la venta propuesta representa menos del 0.002% del flotante total—una cantidad que no se espera que afecte la liquidez, el control o el precio de mercado.

No se reportaron otras ventas durante el período de tres meses anterior. El declarante afirma que no existe información adversa no pública y que la presentación cumple con el requisito de aviso previo de la Regla 144. El documento no indica cambios en las operaciones, las previsiones financieras o la estructura de capital de Kinder Morgan; es estrictamente una divulgación procedimental de una venta rutinaria y de pequeña escala por parte de un insider.

서식 144 제출: 미확인된 Kinder Morgan, Inc. (KMI) 내부자가 Morgan Stanley Smith Barney를 통해 2025년 8월 4일경에 최대 40,000주 보통주를 매도할 의사를 SEC에 알렸습니다. 공지된 암시 가격으로 해당 주식 블록의 가치는 약 112만 4천 달러입니다.

이 주식은 2025년 7월 31일에 권리가 확정된 제한 주식 단위에서 나왔습니다. 약 22억 2,200만 주가 발행된 KMI 주식 중 이번 제안된 매도는 전체 유동 주식의 0.002% 미만으로, 유동성, 지배력 또는 시장 가격에 영향을 미치지 않을 것으로 예상됩니다.

이전 3개월 동안 다른 매도 보고는 없었습니다. 제출자는 비공개 불리한 정보가 없음을 확인하며, 제출은 규칙 144의 사전 통지 요건을 충족합니다. 이 문서는 Kinder Morgan의 운영, 재무 전망 또는 자본 구조에 변동이 없음을 전달하며, 단순히 일상적이고 소규모 내부자 매도에 대한 절차적 공개입니다.

Dépôt du formulaire 144 : Un initié non identifié de Kinder Morgan, Inc. (KMI) a informé la SEC de son intention de vendre jusqu'à 40 000 actions ordinaires vers le 04/08/2025 via Morgan Stanley Smith Barney. Au prix implicite indiqué dans l'avis, le lot vaut environ 1,124 million de dollars.

Les actions proviennent d'unités d'actions restreintes qui ont été acquises le 31/07/2025. Avec environ 2,222 milliards d'actions KMI en circulation, la vente proposée représente moins de 0,002 % du flottant total — un volume qui ne devrait pas influencer la liquidité, le contrôle ou le cours du marché.

Aucune autre vente n'a été signalée au cours des trois mois précédents. Le déclarant affirme qu'il n'existe aucune information défavorable non publique et que la soumission respecte l'exigence de préavis de la règle 144. Le document ne mentionne aucun changement dans les opérations, les prévisions financières ou la structure du capital de Kinder Morgan ; il s'agit strictement d'une divulgation procédurale d'une vente interne de petite envergure et de routine.

Formular 144 Einreichung: Ein nicht identifizierter Insider von Kinder Morgan, Inc. (KMI) hat der SEC die Absicht mitgeteilt, etwa am 04.08.2025 bis zu 40.000 Stammaktien über Morgan Stanley Smith Barney zu verkaufen. Zum im Hinweis angegebenen Preis hat das Aktienpaket einen Wert von ungefähr 1,124 Millionen US-Dollar.

Die Aktien stammen aus Restricted Stock Units, die am 31.07.2025 fällig wurden. Bei rund 2,222 Milliarden ausstehenden KMI-Aktien entspricht der geplante Verkauf weniger als 0,002 % des gesamten Streubesitzes – eine Menge, die voraussichtlich keinen Einfluss auf Liquidität, Kontrolle oder Marktpreis hat.

Im vorangegangenen Dreimonatszeitraum wurden keine weiteren Verkäufe gemeldet. Der Einreicher bestätigt, dass keine nicht-öffentlichen negativen Informationen vorliegen und die Einreichung die Vorankündigungspflicht gemäß Regel 144 erfüllt. Das Dokument enthält keine Änderungen an den Geschäftsaktivitäten, der Finanzprognose oder der Kapitalstruktur von Kinder Morgan; es handelt sich ausschließlich um eine formelle Offenlegung eines routinemäßigen, kleinmaßstäblichen Insiderverkaufs.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine, immaterial Form 144; minimal market impact expected.

This notice covers a prospective sale of 40 k Kinder Morgan shares—about $1.1 M and a de minimis 0.002% of shares outstanding. Originating from recently vested RSUs, the sale looks like a standard diversification or tax-planning move. No aggregation with other insiders is disclosed, and the form includes the customary certification that no undisclosed material information exists. Given the tiny size relative to KMI’s ~$50 B market cap, I view the filing as neutral for valuation or sentiment. Investors generally monitor insider trends, but single Form 144s of this scale rarely move the stock.

Deposito del modulo 144: Un dirigente non identificato di Kinder Morgan, Inc. (KMI) ha notificato alla SEC l'intenzione di vendere fino a 40.000 azioni ordinarie intorno al 04/08/2025 tramite Morgan Stanley Smith Barney. Al prezzo indicato nell'avviso, il blocco vale circa 1,124 milioni di dollari.

Le azioni derivano da unità azionarie vincolate che sono maturate il 31/07/2025. Con circa 2,222 miliardi di azioni KMI in circolazione, la vendita proposta rappresenta meno dello 0,002% del flottante totale—una quantità che non dovrebbe influenzare la liquidità, il controllo o il prezzo di mercato.

Non sono state segnalate altre vendite nel periodo di tre mesi precedente. Il dichiarante conferma che non ci sono informazioni riservate negative e che la comunicazione rispetta il requisito di preavviso della Regola 144. Il documento non segnala cambiamenti nelle operazioni, nelle previsioni finanziarie o nella struttura del capitale di Kinder Morgan; si tratta esclusivamente di una comunicazione procedurale relativa a una vendita interna di piccola entità e di routine.

Presentación del formulario 144: Un insider no identificado de Kinder Morgan, Inc. (KMI) ha notificado a la SEC su la intención de vender hasta 40,000 acciones comunes alrededor del 04/08/2025 a través de Morgan Stanley Smith Barney. Al precio implícito en el aviso, el bloque tiene un valor aproximado de 1.124 millones de dólares.

Las acciones provienen de unidades restringidas de acciones que se consolidaron el 31/07/2025. Con aproximadamente 2.222 mil millones de acciones KMI en circulación, la venta propuesta representa menos del 0.002% del flotante total—una cantidad que no se espera que afecte la liquidez, el control o el precio de mercado.

No se reportaron otras ventas durante el período de tres meses anterior. El declarante afirma que no existe información adversa no pública y que la presentación cumple con el requisito de aviso previo de la Regla 144. El documento no indica cambios en las operaciones, las previsiones financieras o la estructura de capital de Kinder Morgan; es estrictamente una divulgación procedimental de una venta rutinaria y de pequeña escala por parte de un insider.

서식 144 제출: 미확인된 Kinder Morgan, Inc. (KMI) 내부자가 Morgan Stanley Smith Barney를 통해 2025년 8월 4일경에 최대 40,000주 보통주를 매도할 의사를 SEC에 알렸습니다. 공지된 암시 가격으로 해당 주식 블록의 가치는 약 112만 4천 달러입니다.

이 주식은 2025년 7월 31일에 권리가 확정된 제한 주식 단위에서 나왔습니다. 약 22억 2,200만 주가 발행된 KMI 주식 중 이번 제안된 매도는 전체 유동 주식의 0.002% 미만으로, 유동성, 지배력 또는 시장 가격에 영향을 미치지 않을 것으로 예상됩니다.

이전 3개월 동안 다른 매도 보고는 없었습니다. 제출자는 비공개 불리한 정보가 없음을 확인하며, 제출은 규칙 144의 사전 통지 요건을 충족합니다. 이 문서는 Kinder Morgan의 운영, 재무 전망 또는 자본 구조에 변동이 없음을 전달하며, 단순히 일상적이고 소규모 내부자 매도에 대한 절차적 공개입니다.

Dépôt du formulaire 144 : Un initié non identifié de Kinder Morgan, Inc. (KMI) a informé la SEC de son intention de vendre jusqu'à 40 000 actions ordinaires vers le 04/08/2025 via Morgan Stanley Smith Barney. Au prix implicite indiqué dans l'avis, le lot vaut environ 1,124 million de dollars.

Les actions proviennent d'unités d'actions restreintes qui ont été acquises le 31/07/2025. Avec environ 2,222 milliards d'actions KMI en circulation, la vente proposée représente moins de 0,002 % du flottant total — un volume qui ne devrait pas influencer la liquidité, le contrôle ou le cours du marché.

Aucune autre vente n'a été signalée au cours des trois mois précédents. Le déclarant affirme qu'il n'existe aucune information défavorable non publique et que la soumission respecte l'exigence de préavis de la règle 144. Le document ne mentionne aucun changement dans les opérations, les prévisions financières ou la structure du capital de Kinder Morgan ; il s'agit strictement d'une divulgation procédurale d'une vente interne de petite envergure et de routine.

Formular 144 Einreichung: Ein nicht identifizierter Insider von Kinder Morgan, Inc. (KMI) hat der SEC die Absicht mitgeteilt, etwa am 04.08.2025 bis zu 40.000 Stammaktien über Morgan Stanley Smith Barney zu verkaufen. Zum im Hinweis angegebenen Preis hat das Aktienpaket einen Wert von ungefähr 1,124 Millionen US-Dollar.

Die Aktien stammen aus Restricted Stock Units, die am 31.07.2025 fällig wurden. Bei rund 2,222 Milliarden ausstehenden KMI-Aktien entspricht der geplante Verkauf weniger als 0,002 % des gesamten Streubesitzes – eine Menge, die voraussichtlich keinen Einfluss auf Liquidität, Kontrolle oder Marktpreis hat.

Im vorangegangenen Dreimonatszeitraum wurden keine weiteren Verkäufe gemeldet. Der Einreicher bestätigt, dass keine nicht-öffentlichen negativen Informationen vorliegen und die Einreichung die Vorankündigungspflicht gemäß Regel 144 erfüllt. Das Dokument enthält keine Änderungen an den Geschäftsaktivitäten, der Finanzprognose oder der Kapitalstruktur von Kinder Morgan; es handelt sich ausschließlich um eine formelle Offenlegung eines routinemäßigen, kleinmaßstäblichen Insiderverkaufs.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Saich John A.

(Last) (First) (Middle)
C/O SELECT MEDICAL HOLDINGS CORPORATION
4714 GETTYSBURG ROAD

(Street)
MECHANICSBURG PA 17055

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SELECT MEDICAL HOLDINGS CORP [ SEM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EXECUTIVE VICE PRESIDENT
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 F(1) 21,745 D $12.57 736,412 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.
/s/ Michael E. Tarvin, Attorney-in-Fact 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Kinder Morgan (KMI) shares are being registered for sale?

The Form 144 covers 40,000 common shares.

What is the estimated market value of the shares in this Form 144?

The filing lists an aggregate market value of approximately $1.124 million.

When is the insider planning to sell the Kinder Morgan shares?

The approximate sale date is 08/04/2025, subject to market conditions.

What percentage of Kinder Morgan’s total shares does this proposed sale represent?

The block equals less than 0.002% of the roughly 2.222 billion shares outstanding.

Does the Form 144 indicate any other insider sales in the past three months?

No; the table of prior three-month sales states “Nothing to Report.”

Why is a Form 144 filed for this transaction?

Rule 144 requires affiliates to provide advance notice when they plan to sell restricted or control securities, ensuring market transparency.
Select Medical

NYSE:SEM

SEM Rankings

SEM Latest News

SEM Latest SEC Filings

SEM Stock Data

1.46B
109.38M
14.52%
85.52%
2.41%
Medical Care Facilities
Services-hospitals
Link
United States
MECHANICSBURG